ABCB1, ATP binding cassette subfamily B member 1, 5243
N. diseases: 933; N. variants: 59
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.776 | 0.120 | 7 | 87591570 | intron variant | A/G | snv | 0.50 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2009 | 2013 | |||||||
|
0.851 | 0.200 | 7 | 87601024 | 5 prime UTR variant | A/G | snv |
|
Neoplasms | 0.020 | 0.500 | 2 | 2006 | 2008 | ||||||||
|
1.000 | 0.080 | 7 | 87566646 | intron variant | G/A | snv | 0.39 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.763 | 0.440 | 7 | 87536472 | missense variant | C/T | snv |
|
Digestive System Diseases | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||||
|
0.776 | 0.120 | 7 | 87591570 | intron variant | A/G | snv | 0.50 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2009 | 2013 | |||||||
|
0.776 | 0.120 | 7 | 87591570 | intron variant | A/G | snv | 0.50 |
|
0.020 | 0.500 | 2 | 2009 | 2013 | ||||||||
|
0.776 | 0.120 | 7 | 87591570 | intron variant | A/G | snv | 0.50 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2009 | 2013 | |||||||
|
0.776 | 0.120 | 7 | 87591570 | intron variant | A/G | snv | 0.50 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2009 | 2013 | |||||||
|
1.000 | 0.040 | 7 | 87535576 | intron variant | T/A;C;G | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
7 | 87633265 | intron variant | G/A | snv | 0.16 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
0.851 | 0.200 | 7 | 87601024 | 5 prime UTR variant | A/G | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||||
|
0.851 | 0.200 | 7 | 87601024 | 5 prime UTR variant | A/G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
0.851 | 0.200 | 7 | 87601024 | 5 prime UTR variant | A/G | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
0.851 | 0.200 | 7 | 87601024 | 5 prime UTR variant | A/G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.851 | 0.200 | 7 | 87601024 | 5 prime UTR variant | A/G | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||||
|
0.851 | 0.120 | 7 | 87584585 | intron variant | C/T | snv | 0.39 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 7 | 87584585 | intron variant | C/T | snv | 0.39 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 7 | 87584585 | intron variant | C/T | snv | 0.39 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 7 | 87584585 | intron variant | C/T | snv | 0.39 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 7 | 87584585 | intron variant | C/T | snv | 0.39 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 7 | 87584585 | intron variant | C/T | snv | 0.39 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.120 | 7 | 87584585 | intron variant | C/T | snv | 0.39 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 7 | 87583942 | intron variant | C/T | snv | 0.69 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.040 | 7 | 87540386 | intron variant | A/C | snv | 3.9E-02 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 7 | 87540386 | intron variant | A/C | snv | 3.9E-02 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 |